Bill Status of SB 2672   103rd General Assembly

Short Description:  INS CD-GENERIC DRUG SHORTAGE

Senate Sponsors
Sen. Laura M. Murphy-Julie A. Morrison, Mary Edly-Allen, Adriane Johnson, Doris Turner, Emil Jones, III, Christopher Belt, Robert F. Martwick and Paul Faraci

House Sponsors
(Rep. Terra Costa Howard, Laura Faver Dias, Will Guzzardi, Mary Beth Canty, Abdelnasser Rashid, Maura Hirschauer, Nabeela Syed, Camille Y. Lilly, Michael J. Kelly and Joyce Mason)


Last Action  View All Actions

DateChamber Action
  8/2/2024SenatePublic Act . . . . . . . . . 103-0758

Statutes Amended In Order of Appearance
215 ILCS 5/356z.71 new
215 ILCS 125/5-3from Ch. 111 1/2, par. 1411.2
215 ILCS 130/4003from Ch. 73, par. 1504-3
215 ILCS 165/10from Ch. 32, par. 604
305 ILCS 5/5-16.8

Synopsis As Introduced
Amends the Accident and Health Article of the Illinois Insurance Code. Provides that if a generic drug is unavailable due to a supply issue and dosage cannot be adjusted, a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed after January 1, 2025 shall provide coverage for a brand name eligible prescription drug until supply of the generic drug is available. Defines "eligible prescription drug" and "generic drug". Makes conforming changes in the Health Maintenance Organization Act, the Limited Health Service Organization Act, the Voluntary Health Services Plans Act, and the Medical Assistance Article of the Illinois Public Aid Code.

Senate Committee Amendment No. 1
Replaces everything after the enacting clause. Reinserts the provisions of the introduced bill with the following changes. Adds a definition of "unavailable". Provides that if a generic drug or a therapeutic equivalent is unavailable (rather than if a generic drug is unavailable) due to a supply issue and dosage cannot be adjusted, a group or individual policy of accident and health insurance or a managed care plan that is amended, delivered, issued, or renewed after January 1, 2026 (instead of January 1, 2025) shall provide coverage for a brand name eligible prescription drug until supply of the generic drug or a therapeutic equivalent is available.

Actions 
DateChamber Action
  1/10/2024SenateFiled with Secretary by Sen. Laura M. Murphy
  1/10/2024SenateFirst Reading
  1/10/2024SenateReferred to Assignments
  1/31/2024SenateAssigned to Insurance
  2/1/2024SenateAdded as Chief Co-Sponsor Sen. Julie A. Morrison
  2/22/2024SenateSenate Committee Amendment No. 1 Filed with Secretary by Sen. Laura M. Murphy
  2/22/2024SenateSenate Committee Amendment No. 1 Referred to Assignments
  2/28/2024SenateSenate Committee Amendment No. 1 Assignments Refers to Insurance
  3/6/2024SenateSenate Committee Amendment No. 1 Adopted
  3/6/2024SenateDo Pass as Amended Insurance; 007-000-000
  3/6/2024SenatePlaced on Calendar Order of 2nd Reading March 7, 2024
  4/10/2024SenateSecond Reading
  4/10/2024SenatePlaced on Calendar Order of 3rd Reading April 11, 2024
  4/11/2024SenateThird Reading - Passed; 059-000-000
  4/11/2024SenateAdded as Co-Sponsor Sen. Mary Edly-Allen
  4/11/2024SenateAdded as Co-Sponsor Sen. Adriane Johnson
  4/11/2024SenateAdded as Co-Sponsor Sen. Doris Turner
  4/11/2024SenateAdded as Co-Sponsor Sen. Emil Jones, III
  4/11/2024SenateAdded as Co-Sponsor Sen. Christopher Belt
  4/11/2024HouseArrived in House
  4/12/2024HouseChief House Sponsor Rep. Terra Costa Howard
  4/12/2024HouseFirst Reading
  4/12/2024HouseReferred to Rules Committee
  4/12/2024SenateAdded as Co-Sponsor Sen. Robert F. Martwick
  4/16/2024SenateAdded as Co-Sponsor Sen. Paul Faraci
  4/24/2024HouseAssigned to Insurance Committee
  4/30/2024HouseDo Pass / Short Debate Insurance Committee; 015-000-000
  5/1/2024HousePlaced on Calendar 2nd Reading - Short Debate
  5/6/2024HouseSecond Reading - Short Debate
  5/6/2024HousePlaced on Calendar Order of 3rd Reading - Short Debate
  5/14/2024HouseThird Reading - Short Debate - Passed 109-000-000
  5/14/2024SenatePassed Both Houses
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Laura Faver Dias
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Will Guzzardi
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Mary Beth Canty
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Abdelnasser Rashid
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Maura Hirschauer
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Nabeela Syed
  5/14/2024HouseAdded Alternate Co-Sponsor Rep. Camille Y. Lilly
  5/15/2024HouseAdded Alternate Co-Sponsor Rep. Michael J. Kelly
  5/15/2024HouseAdded Alternate Co-Sponsor Rep. Joyce Mason
  6/12/2024SenateSent to the Governor
  8/2/2024SenateGovernor Approved
  8/2/2024SenateEffective Date January 1, 2025
  8/2/2024SenatePublic Act . . . . . . . . . 103-0758

Back To Top